Author: iData Research
DePuy Synthes, Medtronic Leads Europe MIS Interbody Device Market Fueled by Increased Procedure Volumes and Product Innovation
As minimally invasive devices continue to gain popularity in the surgical community, the number of MIS interbody fusion procedures performed in Europe will reach nearly 38,000 by 2023... Read More
2017 US Dental Barrier Membrane Market Driven by Increased Use of Resorbable Membranes
This market’s value is expected to continue growing, demonstrating similar growth patterns in each of the resorbable and non-resorbable solutions. Nonetheless, market growth is threatened by increas... Read More
Vivorté Announces the Commercial Availability of FORTERA and REGENTO Bone Grafting Solutions for Orthopedic Surgery
These newly introduced products join Trabexus EB, which first received 510(k) clearance in 2015. TRABEXUS EB is a self-setting, gradually resorbable, calcium phosphate matrix enhanced with partially ... Read More
Sandoz Proposed Biosimilar Rituximab Accepted for Review by the FDA
Sandoz believes the comprehensive data package submitted to the FDA for review confirms that our biosimilar rituximab matches the reference medicine in terms of safety, efficacy and quality... Read More
Smith & Nephew Welcome Wound Biofilm Report Supporting Dressings
Biofilms are clusters of bacteria that, when present in chronic wounds, are linked to delayed healing, and are resistant to antimicrobial treatments.... Read More
Zimmer Biomet, Wright Medical Lead US Market for Elbow Repair Devices Fueled by Cases of Arthritis and Use of New Anatomic Plates
The U.S. elbow repair device market is driven by incidences of rheumatoid arthritis, the aging population, competitor interest and the development of shorter surgical procedures... Read More
AbbVie Announces Global Resolution of HUMIRA® (adalimumab) Patent Disputes with Amgen Allowing Commercialization Of AMGEVITA™
Agreements Provide Non-Exclusive License to Amgen for HUMIRA-Related Intellectual Property in the U.S. Effective Jan. 31, 2023, And in Other Markets on Different Dates... Read More
FreeStyle Libre Flash Glucose Monitoring Technology Gains Reimbursement Approval from the United Kingdom’s National Health Service
First-of-its-kind product has driven significant reimbursement in key markets, due to exceptional clinical outcome data and proven accuracy. Freestyle Libre system allows people with diabetes to check... Read More
